格隆汇5月6日|美国药厂百时美施贵宝(Bristol-Myers Squibb)准备未来5年,投放400亿美元在美国发展业务。公司首席执行官Christopher Boerner称,有关投资包括加速研发新药品,提升科技水平,以及设立美国厂房生产等项目。不过,Boerner未提及这笔投资是新增的,抑或已公布计划的总额。周一较早时,美国总统特朗普签署行政命令,指示相关部门精简药厂在美国设厂生产所须的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.